Personalized Medicine Market By Application(Health Informatics, Clinical Research, Companion Diagnostics, Biomarker Identification), By End-user(Hospitals, Contract Research Organizations, Molecular Diagnostic Laboratories and Testing facilities Academic Institutes and Research Laboratories, Bio and health informatics companies), By Therapeutic Area(Cardiology, Antiviral, Psychiatry, Oncology, Neurology), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
Personalized Medicine Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.
  • Market Overview:

    Personalized medication is an advanced version of the conventional approaches for the treatment of diseases on an individual level. It is a process of diagnosing and preventing a disease by providing treatment to a patient using the information regarding his/her genetic structure, proteins, and the external environment. It’s a methodology which is based upon the analysis of unique risks associated to a specific person regarding specific diseases. The major advantage of this medicine therapy is that, it incorporates the usage of highly precise equipment and tools, coupled with specialized doctors who determine the treatment on the basis of patient’s molecular profile after the analysis of harmful side effects. This saves the patient from unnecessary delay in the treatment and extra cost which is caused by the conventional trial and error approach. A continuous rise in the number of patients suffering from critical diseases, especially in the developed countries, are getting more oriented towards personalized treatments. This is acting as a major driving factor for the growth of the personalized medicine market. Moreover, persistent research and development activities in the field of medicine, coupled with the rising awareness regarding advanced treatments of chronic diseases such as Cancer and Diabetes will boost the market pace in the near future. Apart from this, favorable initiatives taken by the government to introduce personalized medication therapy, in various countries can emerge out as a major opportunity for the expansion of the very market.

    There are various funded programs supported by the European Union for the development of biotechnology research and personalized medicine. For example, the EU has already sanctioned a fund of more than 3 billion euros for the personalized medication research. This fund has come from the research framework programs FP7 and Horizon 2020. However, high cost of such treatment procedures and lack of awareness regarding personalized medicine in both developing and under- developed countries can act as a hampering agent for the market.

    The report provides detailed qualitative and quantitative analysis of the Personalized Medicine Market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segments namely application, end-user and therapeutic area in each of the major regions.

    Personalized Medicine Market Segmentation

    By Application

    • Health Informatics
    • Clinical Research
    • Companion Diagnostics
    • Biomarker identification

    By End-user

    • Hospitals
    • Contract Research Organizations
    • Molecular Diagnostic Laboratories and Testing facilities
    • Academic Institutes and Research Laboratories
    • Bio and health informatics companies
    • Others

    By Therapeutic area

    • Cardiology
    • Antiviral
    • Psychiatry
    • Oncology
    • Neurology
    • Others

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K.
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources
    CHAPTER 2. PERSONALIZED MEDICINE MARKET OVERVIEW
    2.1. PERSONALIZED MEDICINE MARKET INTRODUCTION
    2.2. GLOBAL PERSONALIZED MEDICINE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global Personalized Medicine Production (VOLUME) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL PERSONALIZED MEDICINE MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global Personalized Medicine Capacity (VOLUME) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL PERSONALIZED MEDICINE MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global Personalized Medicine Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL PERSONALIZED MEDICINE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global Personalized Medicine Consumption (VOLUME) and Growth Rate (%), (2017-2025)
    CHAPTER 3. GLOBAL PERSONALIZED MEDICINE MARKET BY THERAPEUTIC AREA, 2017-2025
    3.1. CARDIOLOGY
    3.2. ANTIVIRAL
    3.3. PSYCHIATRY
    3.4. GLOBAL PERSONALIZED MEDICINE MARKET REVENUE BY THERAPEUTIC AREA, 2017-2025
    3.4.1. Global Personalized Medicine Market Revenue (Million USD) and Share (%) By Therapeutic area, 2017-2025
    3.4.2. Cardiology Market Revenue and Growth Rate, 2017-2025
    3.4.3. Antiviral Market Revenue and Growth Rate, 2017-2025
    3.4.4. Psychiatry Market Revenue and Growth Rate, 2017-2025
    3.5. GLOBAL PERSONALIZED MEDICINE MARKET PRODUCTION BY THERAPEUTIC AREA, 2017-2025
    3.5.1. Global Personalized Medicine Market Production (Volume) and Share (%) By Therapeutic area, 2017-2025
    3.5.2. Cardiology Market Production and Growth Rate, 2017-2025
    3.5.3. Antiviral Market Production and Growth Rate, 2017-2025
    3.5.4. Psychiatry Market Production and Growth Rate, 2017-2025
    Note: Similar information coverage has been provided for other therapeutic area segment.
    CHAPTER 4. GLOBAL PERSONALIZED MEDICINE MARKET BY APPLICATION, 2017-2025
    4.1. HEALTH INFORMATICS
    4.2. COMPANION DIAGNOSTICS
    4.3. BIOMARKER IDENTIFICATION
    4.4. GLOBAL PERSONALIZED MEDICINE MARKET REVENUE BY APPLICATION, 2017-2025
    4.4.1. Global Personalized Medicine Market Revenue (Million USD) and Share (%) By Application, 2017-2025
    4.4.2. Health Informatics Market Revenue and Growth Rate, 2017-2025
    4.4.3. Companion Diagnostics Market Revenue and Growth Rate, 2017-2025
    4.4.4. Biomarker identification Market Revenue and Growth Rate, 2017-2025
    4.5. GLOBAL PERSONALIZED MEDICINE MARKET CONSUMPTION BY APPLICATION, 2017-2025
    4.5.1. Global Personalized Medicine Market Consumption (Volume) and share (%) By Application, 2017-2025
    4.5.2. Health Informatics Market Consumption and Growth Rate, 2017-2025
    4.5.3. Companion Diagnostics Market Consumption and Growth Rate, 2017-2025
    4.5.4. Biomarker identification Market Consumption and Growth Rate, 2017-2025
    Note: Similar information coverage has been provided for other application and end user segment.
    CHAPTER 5. GLOBAL PERSONALIZED MEDICINE MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL PERSONALIZED MEDICINE MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global Personalized Medicine Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
    CHAPTER 6. GLOBAL PERSONALIZED MEDICINE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    6.1. GLOBAL PERSONALIZED MEDICINE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 35
    6.1.1. Global Personalized Medicine Market Production (Volume) and Share (%) By Region, 2017-2025
    6.1.2. Global Personalized Medicine Market Consumption (Volume) and Share (%) By Region, 2017-2025
    6.1.3. North America Market Production and Consumption, 2017-2025
    6.1.4. Europe Market Production and Consumption, 2017-2025
    6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
    6.1.6. South America Market Production and Consumption, 2017-2025
    6.1.7. Rest of the World Market Production and Consumption, 2017-2025
    CHAPTER 7. MARKET DETERMINANTS
    7.1. MARKET DRIVERS
    7.2. MARKET RESTRAINTS
    7.3. MARKET OPPORTUNITIES
    7.4. MARKET DETERMINANTS RADAR CHART
    CHAPTER 8. GLOBAL PERSONALIZED MEDICINE MARKET COMPETITION BY MANUFACTURERS
    8.1. GLOBAL PERSONALIZED MEDICINE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    8.1.1. Global Personalized Medicine Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
    8.2. GLOBAL PERSONALIZED MEDICINE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    8.2.1. Global Personalized Medicine Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    8.3. PERSONALIZED MEDICINE MARKET COMPETITIVE SITUATION AND TRENDS
    8.3.1. Personalized Medicine Market Share (%) of Top 3 Manufacturers
    8.3.2. Personalized Medicine Market Share (%) of Top 5 Manufacturers
    CHAPTER 9. GLOBAL PERSONALIZED MEDICINE MANUFACTURERS ANALYSIS
    9.1. ABBOTT LABORATORIES
    9.1.1. Business Overview
    9.1.2. Company Basic Information
    9.1.3. Personalized Medicine Product Details
    9.1.4. Abbott Laboratories Personalized Medicine Production, Revenue and Gross Margin
    9.2. ASURAGEN, INC.
    9.2.1. Business Overview
    9.2.2. Company Basic Information
    9.2.3. Personalized Medicine Product Details
    9.2.4. ASURAGEN, INC. Personalized Medicine Production, Revenue and Gross Margin
    9.3. BIOMERIEUX SA
    9.3.1. Business Overview
    9.3.2. Company Basic Information
    9.3.3. Personalized Medicine Product Details
    9.3.4. BioMerieux SA Personalized Medicine Production, Revenue and Gross Margin
    9.4. BRISTOL-MYERS SQUIBB
    9.4.1. Business Overview
    9.4.2. Company Basic Information
    9.4.3. Personalized Medicine Product Details
    9.4.4. Bristol-Myers Squibb Personalized Medicine Production, Revenue and Gross Margin
    9.5. CETICS HEALTHCARE TECHNOLOGIES GMBH
    9.5.1. Business Overview
    9.5.2. Company Basic Information
    9.5.3. Personalized Medicine Product Details
    9.5.4. CETICS Healthcare Technologies GmbH Personalized Medicine Production, Revenue and Gross Margin
    9.6. GLAXOSMITHKLINE
    9.6.1. Business Overview
    9.6.2. Company Basic Information
    9.6.3. Personalized Medicine Product Details
    9.6.4. GlaxoSmithKline Personalized Medicine Production, Revenue and Gross Margin
    9.7. IBM CORPORATION
    9.7.1. Business Overview
    9.7.2. Company Basic Information
    9.7.3. Personalized Medicine Product Details
    9.7.4. IBM Corporation Personalized Medicine Production, Revenue and Gross Margin
    9.8. ILLUMINA, INC.
    9.8.1. Business Overview
    9.8.2. Company Basic Information
    9.8.3. Personalized Medicine Product Details
    9.8.4. Illumina, Inc. Personalized Medicine Production, Revenue and Gross Margin
    9.9. LABORATORY CORPORATION OF AMERICA
    9.9.1. Business Overview
    9.9.2. Company Basic Information
    9.9.3. Personalized Medicine Product Details
    9.9.4. Laboratory Corporation of America Personalized Medicine Production, Revenue and Gross Margin
    9.10. F. HOFFMANN-LA ROCHE AG
    9.10.1. Business Overview
    9.10.2. Company Basic Information
    9.10.3. Personalized Medicine Product Details
    9.10.4. F. Hoffmann-La Roche AG Personalized Medicine Production, Revenue and Gross Margin
    CHAPTER 10. PERSONALIZED MEDICINE MARKET VALUE CHAIN ANALYSIS
    10.1. PERSONALIZED MEDICINE INDUSTRIAL CHAIN ANALYSIS
    10.2. PERSONALIZED MEDICINE KEY RAW MATERIALS ANALYSIS
    10.2.1. Key Raw Materials
    10.2.2. Price Trend of Key Raw Materials
    10.2.3. Key Suppliers of Raw Materials
    10.3. CONSUMER ANALYSIS
    10.3.1. Consumer 1
    10.3.2. Consumer 2
    10.3.3. Consumer 3
    10.3.4. Consumer 4

    keyboard_arrow_up
  • • Abbott Laboratories
    • ASURAGEN, INC.
    • bioMerieux SA
    • Bristol-Myers Squibb
    • CETICS Healthcare Technologies GmbH
    • GlaxoSmithKline
    • IBM Corporation
    • Illumina, Inc.
    • Intomics A/S
    • JOHNSON & JOHNSON
    • Laboratory Corporation of America
    • F. Hoffmann-La Roche AG
    • GE Healthcare
    • Gilead Sciences, Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer, Inc.
    • Quest Diagnostics
    • Randox Laboratories
    • SANOFI
    • Almac Group
    • Amgen, Inc.
    • Astellas Pharma, Inc.
    • AstraZeneca PLC
    • Teva Pharmaceuticals Limited
    • Thermo Fisher Scientific

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Personalized Medicine Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Personalized Medicine Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS